Leads investor relations and corporate communications for a public biotechnology company. Develops corporate narrative, investor engagement, shareholder targeting, media and public communications, earnings materials, disclosure strategies, and milestone communications. Advises executives and the Board on investor sentiment, market positioning, reputation, and communications risk. Requires deep biotech capital markets expertise, significant oncology experience, knowledge of advanced biologics, SEC and Reg FD requirements, and established healthcare investor and media relationships.